| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity
|
Prado, Carla M. M.
|
|
2010
|
67 |
1 |
p. 93-101
|
artikel
|
| 2 |
Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer
|
Xenidis, N.
|
|
2010
|
67 |
1 |
p. 69-73
|
artikel
|
| 3 |
Characterization of the in vitro activity of AZD3409, a novel prenyl transferase inhibitor
|
Appels, Natalie M. G. M.
|
|
2010
|
67 |
1 |
p. 137-145
|
artikel
|
| 4 |
Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement
|
Park, In Hae
|
|
2010
|
67 |
1 |
p. 127-136
|
artikel
|
| 5 |
Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2
|
Wang, Shao-Chuan
|
|
2010
|
67 |
1 |
p. 243-244
|
artikel
|
| 6 |
DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity
|
Yang, Chen Guang
|
|
2010
|
67 |
1 |
p. 49-56
|
artikel
|
| 7 |
Effects of methimazole on the elimination of irinotecan
|
Bol, Jessica M. van der
|
|
2010
|
67 |
1 |
p. 231-236
|
artikel
|
| 8 |
Erucylphospho-N,N,N-trimethylpropylammonium (erufosine) is a potential antimyeloma drug devoid of myelotoxicity
|
Yosifov, Deyan Y.
|
|
2010
|
67 |
1 |
p. 13-25
|
artikel
|
| 9 |
Everolimus and PTK/ZK show synergistic growth inhibition in the orthotopic BL16/BL6 murine melanoma model
|
O’Reilly, Terence
|
|
2010
|
67 |
1 |
p. 193-200
|
artikel
|
| 10 |
Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial
|
Xu, Binghe
|
|
2010
|
67 |
1 |
p. 223-230
|
artikel
|
| 11 |
Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial
|
Gibbs, Peter
|
|
2010
|
67 |
1 |
p. 153-163
|
artikel
|
| 12 |
Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase
|
Roman, Nicholas O.
|
|
2010
|
67 |
1 |
p. 183-192
|
artikel
|
| 13 |
In response to Dr. Han’s comments
|
Bobos, Mattheos
|
|
2010
|
67 |
1 |
p. 245
|
artikel
|
| 14 |
Obituary
|
|
|
2010
|
67 |
1 |
p. 1-3
|
artikel
|
| 15 |
Obituary
|
|
|
|
67 |
1 |
p. 1-3
|
artikel
|
| 16 |
Oral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs
|
Rassnick, Kenneth M.
|
|
2010
|
67 |
1 |
p. 165-171
|
artikel
|
| 17 |
Penetration of ifosfamide and its active metabolite 4-OH-ifosfamide into cerebrospinal fluid of patients with CNS malignancies
|
Kiewe, Philipp
|
|
2010
|
67 |
1 |
p. 27-33
|
artikel
|
| 18 |
Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma
|
Reece, Donna E.
|
|
2010
|
67 |
1 |
p. 57-67
|
artikel
|
| 19 |
Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer
|
Feliu, J.
|
|
2010
|
67 |
1 |
p. 215-221
|
artikel
|
| 20 |
Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets
|
Lee, Dae Ho
|
|
2010
|
67 |
1 |
p. 35-39
|
artikel
|
| 21 |
Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin
|
Bao, Han Ying
|
|
2010
|
67 |
1 |
p. 147-152
|
artikel
|
| 22 |
Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma
|
Rivera, Fernando
|
|
2010
|
67 |
1 |
p. 75-82
|
artikel
|
| 23 |
Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding
|
Choi, Moon Ki
|
|
2010
|
67 |
1 |
p. 5-11
|
artikel
|
| 24 |
Pioglitazone modulates tumor cell metabolism and proliferation in multicellular tumor spheroids
|
Gottfried, Eva
|
|
2010
|
67 |
1 |
p. 117-126
|
artikel
|
| 25 |
Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial
|
Dalla Chiesa, Matteo
|
|
2010
|
67 |
1 |
p. 41-48
|
artikel
|
| 26 |
Serological immune responses to influenza vaccine in patients with colorectal cancer
|
Puthillath, Ajithkumar
|
|
2010
|
67 |
1 |
p. 111-115
|
artikel
|
| 27 |
Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen
|
Kurita, Akinobu
|
|
2010
|
67 |
1 |
p. 201-213
|
artikel
|
| 28 |
The antioxidant ascorbic acid mobilizes nuclear copper leading to a prooxidant breakage of cellular DNA: implications for chemotherapeutic action against cancer
|
Ullah, M. F.
|
|
2010
|
67 |
1 |
p. 103-110
|
artikel
|
| 29 |
The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin
|
Wittenburg, Luke A.
|
|
2010
|
67 |
1 |
p. 83-92
|
artikel
|
| 30 |
The small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1
|
Fujita, Ken-ichi
|
|
2010
|
67 |
1 |
p. 237-241
|
artikel
|
| 31 |
Ultrasound-guided intratumoral administration of collagenase-2 improved liposome drug accumulation in solid tumor xenografts
|
Zheng, Xiangpeng
|
|
2010
|
67 |
1 |
p. 173-182
|
artikel
|
Tijdschrift beschrijving